Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1992 1
1993 1
1999 1
2002 1
2003 1
2004 1
2005 2
2006 2
2007 1
2008 1
2009 3
2010 6
2011 15
2012 16
2013 8
2014 2
2015 2
2016 5
2017 2
2018 8
2019 5
2020 9
2021 8
2022 1
2023 6
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

96 results

Results by year

Filters applied: . Clear all
Page 1
Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir.
González-Cordón A, Assoumou L, Moyle G, Waters L, Johnson M, Domingo P, Fox J, Stellbrink HJ, Guaraldi G, Masiá M, Gompels M, De Wit S, Florence E, Esser S, Raffi F, Behrens G, Pozniak A, Gatell JM, Martínez E; NEAT 022 Study Group. González-Cordón A, et al. J Antimicrob Chemother. 2023 Sep 5;78(9):2361-2365. doi: 10.1093/jac/dkad247. J Antimicrob Chemother. 2023. PMID: 37539492
Reply to Childs et al.
Gervasoni C, Meraviglia P, Cattaneo D. Gervasoni C, et al. Among authors: meraviglia p. Clin Infect Dis. 2020 Nov 5;71(8):2023. doi: 10.1093/cid/ciaa659. Clin Infect Dis. 2020. PMID: 32459828 No abstract available.
When the absence of an interaction can become clinically relevant.
Cattaneo D, Bernacchia D, Beltrami M, Resnati C, Meraviglia P, Gervasoni C. Cattaneo D, et al. Among authors: meraviglia p. AIDS. 2021 Jul 1;35(8):1327-1328. doi: 10.1097/QAD.0000000000002878. AIDS. 2021. PMID: 34076620 No abstract available.
Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial.
Waters L, Assoumou L, González-Cordón A, Rusconi S, Domingo P, Gompels M, de Wit S, Raffi F, Stephan C, Masiá M, Rockstroh J, Katlama C, Behrens GMN, Moyle G, Johnson M, Fox J, Stellbrink HJ, Guaraldi G, Florence E, Esser S, Gatell JM, Pozniak A, Martínez E; NEAT 022 Study Group. Waters L, et al. Clin Infect Dis. 2023 Mar 4;76(5):861-870. doi: 10.1093/cid/ciac827. Clin Infect Dis. 2023. PMID: 36259527 Clinical Trial.
Determinants of bone diseases in tenofovir-treated HIV patients.
Gervasoni C, Minisci D, Meraviglia P, Baldelli S, Clementi E, Rizzardini G, Cattaneo D. Gervasoni C, et al. Among authors: meraviglia p. AIDS. 2016 Jun 19;30(10):1686-7. doi: 10.1097/QAD.0000000000001094. AIDS. 2016. PMID: 27243779 Free article. No abstract available.
Comorbidity Burden and Suboptimal Immunological Responses to Coronavirus Disease 2019 Vaccination in People Living with Human Immunodeficiency Virus.
Cossu MV, Mileto D, Giacomelli A, Oreni L, Bracchitta F, Pellicciotta M, Salari F, Petri F, Meraviglia P, Antinori S, Rizzardini G, Ridolfo AL. Cossu MV, et al. Among authors: meraviglia p. J Infect Dis. 2023 Mar 1;227(5):733-735. doi: 10.1093/infdis/jiac286. J Infect Dis. 2023. PMID: 35796710 Free PMC article. No abstract available.
A novel methodology for large-scale phylogeny partition.
Prosperi MC, Ciccozzi M, Fanti I, Saladini F, Pecorari M, Borghi V, Di Giambenedetto S, Bruzzone B, Capetti A, Vivarelli A, Rusconi S, Re MC, Gismondo MR, Sighinolfi L, Gray RR, Salemi M, Zazzi M, De Luca A; ARCA collaborative group. Prosperi MC, et al. Nat Commun. 2011;2:321. doi: 10.1038/ncomms1325. Epub 2011 May 24. Nat Commun. 2011. PMID: 21610724 Free PMC article.
96 results